Biomerica (BMRA) Financial Statements & Analysis

Biomerica (BMRA) Income Statement

Biomerica reported revenue of $4.45M in fiscal 2026 (fiscal year ended May 31, 2026), down 16.2% from $5.31M a year earlier. Biomerica posted a net loss of $3.77M, compared with a net loss of $4.97M a year earlier. Gross margin was 8.1% and operating margin -119.5%. In the most recent quarter, Q1 fiscal 2027 (ended Aug 31, 2026), revenue was $1.26M, down 8.3% from the same quarter a year earlier.

Biomerica Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Biomerica, Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	May 2026	May 2025	May 2024	May 2023	May 2022	May 2021	Aug 2020	May 2019	May 2018	May 2017
Revenue & Gross Profit
Revenue	4.45	5.31	5.42	5.34	18.87	7.20	6.69	5.20	5.56	5.79
Cost of Revenue	4.09	4.81	4.80	4.89	15.89	6.83	4.91	3.91	3.81	3.77
Gross Profit	0.36	0.50	0.61	0.45	2.98	0.37	1.78	1.29	1.75	2.02
Operating Expenses
Research & Development	0.79	1.02	1.49	1.58	1.81	2.19	1.91	1.68	1.40	1.13
Selling, General & Administrative	4.89	4.61	5.49	6.09	5.70	5.67	2.27	2.03	1.84	1.85
Operating Expenses	5.68	5.64	6.98	7.67	7.51	7.87	4.18	3.70	3.24	2.98
Operating Income	-5.32	-5.14	-6.37	-7.22	-4.53	-7.50	-2.40	-2.41	-1.48	-0.95
Other Income/Expense
Interest Income	1.23	0.17	0.43	0.13	0.03	0.07	0.07	0.04	0.05	0.05
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	1.57	0.17	0.43	0.00	0.03	0.07	0.07	0.04	0.05	0.05
Income
Income Before Tax	-3.75	-4.97	-5.94	-7.09	-4.51	-7.43	-2.33	-2.37	-1.43	-0.91
Income Tax Expense	0.02	0.00	0.04	0.05	0.02	0.01	0.01	0.02	0.03	0.00
Net Income	-3.78	-4.97	-5.98	-7.14	-4.53	-7.45	-2.34	-2.39	-1.47	-0.91
Net Income - Continuous Operations	-3.78	-4.97	-5.98	-7.14	-4.53	-7.45	-2.34	-2.39	-1.47	-0.91
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	-5.24	-4.74	-5.99	-6.87	-3.94	-7.06	-1.93	-2.21	-1.25	-0.69
EBIT	-5.32	-5.14	-6.37	-7.22	-4.53	-7.50	-	-	-	-
Depreciation & Amortization	0.42	0.40	0.37	0.35	0.60	0.38	0.40	0.16	0.19	0.22
Earnings Per Share
Basic EPS	-1.00	-2.00	-3.00	-4.00	-3.00	-1.00	-	-	-	-
Diluted EPS	-1.00	-2.00	-3.00	-4.00	-3.00	-1.00	-	-	-	-
Basic Shares Outstanding	2.91	2.30	2.10	1.77	1.58	11.93	10.17	9.21	8.57	8.26
Diluted Shares Outstanding	2.91	2.30	2.10	1.77	1.58	11.93	10.17	9.21	8.57	8.33

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About Biomerica Financial Statements

What was Biomerica's revenue in fiscal 2026?

Biomerica reported revenue of $4.45M in fiscal 2026 (fiscal year ended May 31, 2026). That was down 16.2% from $5.31M a year earlier.

Is Biomerica profitable?

No. Biomerica reported a net loss of $3.77M in fiscal 2026. In fiscal 2025 it lost $4.97M.

What is Biomerica's operating margin?

Biomerica's operating income was −$5.32M on revenue of $4.45M in fiscal 2026, an operating margin of -119.5%, compared with -96.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition